Vimarsana.com
Latest Breaking News On - Co primary sign endpoint - Page 1 : vimarsana.com
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
On an Intent-to-Treat Analysis, Co-Primary Symptom Endpoint Met, Statistical Significance (P<0.025) Multiple Secondary Symptom Endpoints Met, Statistical...
United-states
American
Securities-exchange
Company-to-host-conference-call
Palatin-technologies-inc
Prnewswire-palatin-technologies-inc
Intent-to-treat-analysis
Co-primary-symptom-endpoint-met
Statistical-significance
Secondary-symptom-endpoints-met
Co-primary-sign-endpoint
vimarsana © 2020. All Rights Reserved.